DigestRedComo funciona
Red
/
Empresas
Br
No verificado

Bristol Myers Squibb

Sobre qué escribimos

BiotecnologíaFarmacéuticaIndustriaMedicina - VariosSalud

157 Comunicados de prensa

Ver todos los comunicados de prensa
18/09/2026
Biotecnología
Salud
Ciencia
Farmacéutica
Web y redes sociales
Telefonía
Finanzas
Mercado de valores
Bristol Myers Squibb to Report Results for Third Quarter 2026 on October 29, 2026
Fuente
Bristol Myers Squibb
Editor
Business Wire
1.00
0
17/09/2026
Salud
Medicina - Varios
Ciencia
Farmacéutica
Biotecnología
Eventos
Industria
Bristol Myers Squibb Presents Sotyktu (deucravacitinib) Data Showing Durable Efficacy, Consistent Safety in Adults with Psoriatic Arthritis Over Two Years
Fuente
Bristol Myers Squibb
Editor
Business Wire
1.00
0
16/09/2026
Biotecnología
Salud
Farmacéutica
Medicina - Varios
Oncología
Acciones y Obligaciones
Bristol Myers Squibb Announces Dividend
Fuente
Bristol Myers Squibb
Editor
Business Wire
1.00
0
08/09/2026
Industria
Ciencia
Biotecnología
Farmacéutica
Oncología
Sanidad
Salud
Medicina - Varios
Bristol Myers Squibb Announces Positive Topline Results from Registrational Phase 2 QUINTESSENTIAL Trial of the Potential First-in-Class GPRC5D-Directed CAR T Cell Therapy, Arlocabtagene Autoleucel ...
Fuente
Bristol Myers Squibb
Editor
Business Wire
1.00
0
29/08/2026
Eventos
Industria
Ciencia
Medicina - Varios
Cardiología
Sanidad
Biotecnología
Farmacéutica
Salud
Bristol Myers Squibb Presents Data Up to Five Years Reinforcing the Long-Term Efficacy and Safety of Camzyos (mavacamten) in Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM) at the European Society of Cardiology (ESC) Congress 2026
Fuente
Bristol Myers Squibb
Editor
Business Wire
1.00
0
13/08/2026
U.S. FDA Grants Accelerated Approval to Bristol Myers Squibb's First CELMoD Therapy ZENBEXUS™, in Combination with Daratumumab and Hyaluronidase-fihj and Dexamethasone (ZDd) for Patients with Multiple Myeloma, as Early as First Relapse
Fuente
Bristol Myers Squibb
Editor
Business Wire
1.00
0
10/08/2026
Bristol Myers Squibb Advances U.S. Manufacturing Investment with New $2.3 Billion Campus in Houston, Texas
Fuente
Bristol Myers Squibb
Editor
Business Wire
1.00
0
30/07/2026
Web y redes sociales
Telefonía
Mercado de valores
Biotecnología
Salud
Ciencia
Farmacéutica
Bristol Myers Squibb Reports Second Quarter Financial Results for 2026
Fuente
Bristol Myers Squibb
Editor
Business Wire
1.00
0
20/07/2026
Mercado laboral
Industria
Sanidad
Técnica
Farmacéutica
Tecnología
Ciencia
Biotecnología
Software
Salud
Bristol Myers Squibb to Build the Most Powerful AI Factory in Life Sciences with NVIDIA
Fuente
Bristol Myers Squibb
Editor
Business Wire
1.00
0
13/07/2026
Industria
Ciencia
Higiene alimentaria
Biotecnología
Sanidad
Farmacéutica
Salud
U.S. Food and Drug Administration Accepts Bristol Myers Squibb's New Drug Application for Mezigdomide in Patients with Relapsed or Refractory Multiple Myeloma
Fuente
Bristol Myers Squibb
Editor
Business Wire
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0